Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Graham Radford-Smith

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
The Lancet. Gastroenterology & Hepatology|September 5, 2024
Intensified versus standard dose infliximab induction therapy for steroid-refractory acute severe ulcerative colitis (PREDICT-UC): an open-label, multicentre, randomised controlled trialMatthew C Choy, Christopher F D Li Wai Suen, Danny Con, et al.
Lancet (London, England)|December 28, 2014
Crohn's disease management after intestinal resection: a randomised trialPeter De Cruz, Michael A Kamm, Amy L Hamilton, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|December 12, 2025
Australian Real-World Effectiveness and Safety of Ustekinumab for the Treatment of Crohn's Disease: Results of the AURORA Study, Including the ANZIBD ConsortiumYoon-Kyo An, Niamh Lindsay, Natalie Allan, et al.
Inflammatory Bowel Diseases|May 30, 2019
Anti-TNF Therapy in Pregnant Women With Inflammatory Bowel Disease: Effects of Therapeutic Strategies on Disease Behavior and Birth OutcomesMette Julsgaard, Christian L Hvas, Richard B Gearry, et al.
Plos Genetics|September 27, 2013
Deep resequencing of GWAS loci identifies rare variants in CARD9, IL23R and RNF186 that are associated with ulcerative colitisMélissa Beaudoin, Philippe Goyette, Gabrielle Boucher, et al.
Gastroenterology|August 6, 2016
A Pleiotropic Missense Variant in SLC39A8 Is Associated With Crohn's Disease and Human Gut Microbiome CompositionDalin Li, Jean-Paul Achkar, Talin Haritunians, et al.
Lancet (London, England)|October 23, 2015
Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association studyIsabelle Cleynen, Gabrielle Boucher, Luke Jostins, et al.
Nature Genetics|September 15, 2014
HLA-DQA1-HLA-DRB1 variants confer susceptibility to pancreatitis induced by thiopurine immunosuppressantsGraham A Heap, Michael N Weedon, Claire M Bewshea, et al.
Journal of Crohn'S & Colitis|December 2, 2015
Clinical Features and HLA Association of 5-Aminosalicylate (5-ASA)-induced Nephrotoxicity in Inflammatory Bowel DiseaseGraham A Heap, Kenji So, Mike Weedon, et al.
Nature Genetics|January 22, 2020
Multitrait analysis of glaucoma identifies new risk loci and enables polygenic prediction of disease susceptibility and progressionJamie E Craig, Xikun Han, Ayub Qassim, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
The Lancet. Gastroenterology & Hepatology|September 5, 2024
Intensified versus standard dose infliximab induction therapy for steroid-refractory acute severe ulcerative colitis (PREDICT-UC): an open-label, multicentre, randomised controlled trialMatthew C Choy, Christopher F D Li Wai Suen, Danny Con, et al.
Lancet (London, England)|December 28, 2014
Crohn's disease management after intestinal resection: a randomised trialPeter De Cruz, Michael A Kamm, Amy L Hamilton, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|December 12, 2025
Australian Real-World Effectiveness and Safety of Ustekinumab for the Treatment of Crohn's Disease: Results of the AURORA Study, Including the ANZIBD ConsortiumYoon-Kyo An, Niamh Lindsay, Natalie Allan, et al.
Inflammatory Bowel Diseases|May 30, 2019
Anti-TNF Therapy in Pregnant Women With Inflammatory Bowel Disease: Effects of Therapeutic Strategies on Disease Behavior and Birth OutcomesMette Julsgaard, Christian L Hvas, Richard B Gearry, et al.
Plos Genetics|September 27, 2013
Deep resequencing of GWAS loci identifies rare variants in CARD9, IL23R and RNF186 that are associated with ulcerative colitisMélissa Beaudoin, Philippe Goyette, Gabrielle Boucher, et al.
Gastroenterology|August 6, 2016
A Pleiotropic Missense Variant in SLC39A8 Is Associated With Crohn's Disease and Human Gut Microbiome CompositionDalin Li, Jean-Paul Achkar, Talin Haritunians, et al.
Lancet (London, England)|October 23, 2015
Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association studyIsabelle Cleynen, Gabrielle Boucher, Luke Jostins, et al.
Nature Genetics|September 15, 2014
HLA-DQA1-HLA-DRB1 variants confer susceptibility to pancreatitis induced by thiopurine immunosuppressantsGraham A Heap, Michael N Weedon, Claire M Bewshea, et al.
Journal of Crohn'S & Colitis|December 2, 2015
Clinical Features and HLA Association of 5-Aminosalicylate (5-ASA)-induced Nephrotoxicity in Inflammatory Bowel DiseaseGraham A Heap, Kenji So, Mike Weedon, et al.
Nature Genetics|January 22, 2020
Multitrait analysis of glaucoma identifies new risk loci and enables polygenic prediction of disease susceptibility and progressionJamie E Craig, Xikun Han, Ayub Qassim, et al.
Pageof 8